Prescription Required.Why?
Is the active ingredient.
Chronic myeloid leukemia (CML)
Gastrointestinal stromal tumors (GIST)
Certain types of acute lymphoblastic leukemia (ALL)
Chronic eosinophilic leukemia, not otherwise specified (CEL, NOS)
Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα (MLPDGFRα)
Resimat 100mg Capsule (Imatinib Mesylate) is a tyrosine kinase inhibitor. It works by blocking the activity of certain enzymes (tyrosine kinases), such as BCR-ABL, KIT, and PDGFRα, which are crucial for the growth and survival of cancer cells. By inhibiting these enzymes, imatinib slows down or stops the growth of cancer cells.
Store at room temperature (20°C to 25°C; 68°F to 77°F). Protect from moisture and light. Keep out of the reach of children.
Dosage is determined by your doctor based on your specific condition and response to treatment.
It is typically taken orally, once or twice daily, with or without food.
Never change your dose or stop taking the medication without consulting your doctor.
Nausea
Vomiting
Diarrhea
Muscle cramps
Fluid retention (edema)
Fatigue
Rash
Headaches
Liver dysfunction
Heart problems (rare but serious)
Increased risk of infection
Alcohol consumption may interact with imatinib. Discuss with your doctor.
Imatinib can cause fatigue and dizziness. Avoid driving or operating machinery if affected.
Imatinib may harm a developing fetus or infant. Consult your doctor before becoming pregnant or breastfeeding while taking this medication.
Dosage and safety in children vary. A doctor will determine appropriate use.
Kidney impairment may affect imatinib's metabolism. Your doctor will adjust your dose accordingly.
Liver impairment may affect imatinib's metabolism. Your doctor will adjust your dose accordingly.
Your doctor or pharmacist
The prescribing information provided with your medication
Reputable medical websites and journals (e.g., Mayo Clinic, National Cancer Institute)
